Filters

Michele Figus, Paolo Fogagnolo, Stefano Lazzeri, Federica Capizzi, Mariachiara Romagnoli, Annalisa Canovetti, Michele Iester, Antonio Ferreras, Luca Rossetti, Marco Nardi

European journal of ophthalmology 2010;20(5):811-8

Full Text

Abstract

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.

Mehmet Borazan, Aylin Karalezli, Yonca Aydin Akova, Ahmet Akman, Halil Kiyici, Selim S Erbek

Acta ophthalmologica 2009;87(5):549-54

Free Full Text

Abstract

Results: 1 – 8 / 8

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Dibenzoxepins""[mesh_terms]

A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model.

Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: a comparison of olopatadine and ketotifen.

A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis.

Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.

Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.

Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.

Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.

Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.

Results for
""Dibenzoxepins""[mesh_terms]